Electroporation-Based Treatments in Small Animal Veterinary Oral and Maxillofacial Oncology.
cats
dogs
electrochemotherapy (ECT)
electroporation
gene electrotransfer
oral tumors
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
06
2020
accepted:
27
08
2020
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Electroporation is a method of inducing an increase in permeability of the cell membrane through the application of an electric field and can be used as a delivery method for introducing molecules of interest (e.g., chemotherapeutics or plasmid DNA) into cells. Electroporation-based treatments (i.e., electrochemotherapy, gene electrotransfer, and their combinations) have been shown to be safe and effective in veterinary oncology, but they are currently mostly recommended for the treatment of those solid tumors for which clients have declined surgery and/or radiotherapy. Published data show that electroporation-based treatments are also safe, simple, fast and cost-effective treatment alternatives for selected oral and maxillofacial tumors, especially small squamous cell carcinoma and malignant melanoma tumors not involving the bone in dogs. In these patients, a good local response to treatment is expected to result in increased survival time with good quality of life. Despite emerging evidence of the clinical efficacy of electroporation-based treatments for oral and maxillofacial tumors, further investigation is needed to optimize treatment protocols, improve clinical data reporting and better understand the mechanisms of patients' response to the treatment.
Identifiants
pubmed: 33134356
doi: 10.3389/fvets.2020.575911
pmc: PMC7550461
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
575911Informations de copyright
Copyright © 2020 Nemec, Milevoj, Lampreht Tratar, Serša, Čemažar and Tozon.
Références
Vet Surg. 1991 Nov-Dec;20(6):397-401
pubmed: 1369522
J Vis Exp. 2016 Oct 24;(116):
pubmed: 27805594
J Feline Med Surg. 2014 Apr;16(4):291-9
pubmed: 24127456
Eur J Cancer. 2016 Aug;63:41-52
pubmed: 27267144
Eur J Surg Oncol. 2019 Feb;45(2):92-102
pubmed: 30528893
PLoS One. 2018 May 31;13(5):e0198342
pubmed: 29852000
PLoS One. 2016 Jun 08;11(6):e0157176
pubmed: 27276060
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785329
pubmed: 29986632
J Am Vet Med Assoc. 2018 Jul 1;253(1):73-83
pubmed: 29911943
Vet Rec. 2016 Dec 17;179(24):627
pubmed: 27758950
Biochem Pharmacol. 1988 Dec 15;37(24):4727-33
pubmed: 2462423
Clin Transl Med. 2019 May 13;8(1):16
pubmed: 31081530
Vet J. 2016 Nov;217:18-25
pubmed: 27810205
Vet Comp Oncol. 2017 Dec;15(4):1187-1205
pubmed: 27506827
J Natl Cancer Inst. 2002 May 15;94(10):762-8
pubmed: 12011227
Open Vet J. 2019 Apr;9(1):88-93
pubmed: 31086772
Cardiovasc Intervent Radiol. 2019 Dec;42(12):1806-1809
pubmed: 31440783
Mol Ther. 2002 Jun;5(6):668-75
pubmed: 12027550
Eur J Surg Oncol. 2018 May;44(5):651-657
pubmed: 29402556
Vet Comp Oncol. 2018 Mar;16(1):E169-E175
pubmed: 29152844
Cancer Gene Ther. 2010 Aug;17(8):571-8
pubmed: 20414325
Radiol Oncol. 2016 Feb 16;50(1):1-13
pubmed: 27069444
J Mol Med (Berl). 2001;78(12):692-702
pubmed: 11434722
Radiol Oncol. 2020 Feb 19;54(1):79-85
pubmed: 32074076
J Am Vet Med Assoc. 2015 Nov 15;247(10):1146-53
pubmed: 26517618
Front Vet Sci. 2015 Apr 01;2:5
pubmed: 26664934
Cancer Chemother Pharmacol. 2016 May;77(5):939-47
pubmed: 26992379
BMC Cancer. 2013 Jan 29;13:38
pubmed: 23360213
Anticancer Drugs. 2000 Mar;11(3):201-8
pubmed: 10831279
Vet Immunol Immunopathol. 2019 Jan;207:10-17
pubmed: 30593345
Acta Oncol. 2018 Jul;57(7):874-882
pubmed: 29577784
J Membr Biol. 2015 Oct;248(5):909-17
pubmed: 25840833
Curr Gene Ther. 2015;15(1):44-54
pubmed: 25429465
Vet Comp Oncol. 2020 Sep;18(3):428-432
pubmed: 31419028
Equine Vet J. 2012 Mar;44(2):214-20
pubmed: 21793876
Endosc Int Open. 2018 Jun;6(6):E727-E734
pubmed: 29868638
J Cell Mol Med. 2015 Mar;19(3):664-75
pubmed: 25628149
Open Vet J. 2017;7(1):57-60
pubmed: 28331834
J Am Vet Med Assoc. 1997 Mar 15;210(6):778-84
pubmed: 9074679
Biomed Eng Online. 2015;14 Suppl 3:S4
pubmed: 26356007
Breast Cancer Res Treat. 2012 Aug;134(3):1169-78
pubmed: 22821399
Eur J Surg Oncol. 2013 Jan;39(1):4-16
pubmed: 22980492
Ann Biomed Eng. 2005 Feb;33(2):223-31
pubmed: 15771276
Radiol Oncol. 2017 Sep 14;51(3):286-294
pubmed: 28959165
Mediators Inflamm. 2017;2017:5285890
pubmed: 28596641
Vet Comp Oncol. 2005 Mar;3(1):16-24
pubmed: 19379210
J Transl Med. 2017 Jul 1;15(1):151
pubmed: 28668095
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Res Vet Sci. 2019 Feb;122:40-49
pubmed: 30453179
Head Neck. 2018 Jan;40(1):120-125
pubmed: 29130624
J Immunother Cancer. 2019 Nov 27;7(1):325
pubmed: 31775882
Clin Cancer Res. 2014 Jul 15;20(14):3753-62
pubmed: 24874834
Melanoma Res. 2006 Feb;16(1):23-7
pubmed: 16432452
J Transl Med. 2012 Nov 21;10:234
pubmed: 23171444
Cytokine Growth Factor Rev. 2015 Oct;26(5):559-68
pubmed: 26182974
Hum Gene Ther. 2008 Nov;19(11):1261-71
pubmed: 19866490
Anticancer Res. 2005 Mar-Apr;25(2A):839-45
pubmed: 15868917
Vet Comp Oncol. 2017 Jun;15(2):641-654
pubmed: 26840222
Cancer Immunol Immunother. 2015 Oct;64(10):1315-27
pubmed: 26067277
Br J Cancer. 2008 Jan 29;98(2):388-98
pubmed: 18182988
J Am Vet Med Assoc. 2001 Jun 1;218(11):1783-6
pubmed: 11394830
Endosc Int Open. 2020 Feb;8(2):E124-E132
pubmed: 32010744
Curr Gene Ther. 2016;16(2):98-129
pubmed: 27029943
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Clin Case Rep. 2017 Nov 13;5(12):2127-2132
pubmed: 29225870
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):967-979
pubmed: 31176458
J Small Anim Pract. 2017 Mar;58(3):146-153
pubmed: 28224623
Vet Comp Oncol. 2019 Sep;17(3):234-241
pubmed: 30688021
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Vet Med Sci. 2020 Aug;6(3):290-298
pubmed: 31910331
J Membr Biol. 2010 Jul;236(1):3-13
pubmed: 20617432
Anticancer Drugs. 1998 Apr;9(4):319-25
pubmed: 9635922
Can Vet J. 2013 Jun;54(6):606-9
pubmed: 24155455
IEEE Trans Biomed Eng. 2015 Jan;62(1):4-20
pubmed: 25389236
Radiol Oncol. 2017 Nov 1;51(4):422-430
pubmed: 29333121
Annu Rev Biomed Eng. 2014 Jul 11;16:295-320
pubmed: 24905876
Biomed Eng Online. 2014 Mar 12;13(1):29
pubmed: 24621079
Bioelectrochemistry. 2017 Apr;114:33-41
pubmed: 28006672
J Clin Oncol. 2008 Dec 20;26(36):5896-903
pubmed: 19029422
Int J Cancer. 2009 Aug 1;125(3):698-707
pubmed: 19431145
Ther Adv Med Oncol. 2019 Jun 06;11:1758835919855491
pubmed: 31217827
J Immunother Cancer. 2019 Apr 17;7(1):108
pubmed: 30995949
Radiol Oncol. 2013 Mar;47(1):32-41
pubmed: 23450195
Methods Mol Biol. 2008;423:319-25
pubmed: 18370210
NMR Biomed. 2014 Mar;27(3):320-31
pubmed: 24395616
Cancer Res. 1995 Aug 1;55(15):3450-5
pubmed: 7614485
Cancer. 2010 Apr 1;116(7):1757-66
pubmed: 20143437
J Am Vet Med Assoc. 2015 Feb 15;246(4):455-7
pubmed: 25632821
Mol Ther. 2005 Nov;12(5):942-9
pubmed: 15953768
J Control Release. 2018 Apr 28;276:30-41
pubmed: 29476881
J Surg Oncol. 2014 Sep;110(3):320-7
pubmed: 24782355
Clin Cancer Res. 2006 May 15;12(10):3177-83
pubmed: 16707618
In Vivo. 2009 Jan-Feb;23(1):55-62
pubmed: 19368125
Cancer Biol Ther. 2009 Nov;8(22):2114-22
pubmed: 19755854
J Exp Clin Cancer Res. 2003 Dec;22(4):571-80
pubmed: 15053299
Radiol Oncol. 2011 Mar;45(1):31-9
pubmed: 22933932
Radiol Oncol. 2020 Mar 7;54(1):68-78
pubmed: 32187017
Eur J Surg Oncol. 2020 Sep;46(9):1628-1633
pubmed: 32387070
Int J Surg. 2017 Aug;44:26-32
pubmed: 28624558
Vet Comp Oncol. 2017 Sep;15(3):775-784
pubmed: 27001443
Croat Med J. 2007 Jun;48(3):391-5
pubmed: 17589984
Biomedicines. 2017 Jun 28;5(3):
pubmed: 28657611
Vet Comp Oncol. 2017 Sep;15(3):996-1013
pubmed: 27146852
Vet J. 2009 Jan;179(1):117-20
pubmed: 17904882
In Vivo. 2008 Nov-Dec;22(6):751-3
pubmed: 19181001
Curr Gene Ther. 2010 Aug;10(4):300-11
pubmed: 20560875
Artif Organs. 2018 Mar;42(3):297-304
pubmed: 29027689